FOCAL MEDICAL, INC.

Profile

Company Names

FOCAL MEDICAL, INC.
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.

Addresses

111 JAMES JACKSON AVENUE, SUITE 131, CARY, NC 27513

2301 STONEHENGE DRIVE, SUITE 204, RALEIGH, NC 27615

Phone Numbers

919-917-7324

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$6,449,993.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-02-21 
$950,000.00 
$950,000.00 
$0.00 
 
1
2020-10-23 
$5,499,993.00 
$14,100,000.00 
$8,600,007.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
ALDRIDGE 
EXECUTIVE OFFICER, DIRECTOR
SARATOGA RESOURCES INC /TX   |  ALLON THERAPEUTICS INC   |  FOCAL MEDICAL, INC.
NESSAN 
 
BERMINGHAM 
DIRECTOR
INTELLIA THERAPEUTICS, INC.   |  KORRO BIO, INC.   |  FOCAL MEDICAL, INC.
JOSEPH 
 
DESIMONE 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.   |  BLUE CURRENT, INC.   |  FOCAL MEDICAL, INC.   |  OMNIPULSE BIOSCIENCES, INC.   |  TEAL HEALTH, INC.   |  CONTINUITY BIOSCIENCES, LLC
ANTHONY 
S. 
VOIERS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
JEN JEN 
 
YEH 
DIRECTOR
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.   |  FOCAL MEDICAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-02-21 
2020-11-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#